News from the MCRC
Research Spotlight
04/10/2022
Gene mutations should be tested routinely for ovarian cancer, say scientists
Scientists from The University of Manchester have shown that testing for two gene families linked to a lifetime epithelial ovarian cancer risk of between 5% and 20% has a much higher than expected detection rate.
Director's Update
30/09/2022
MCRC Director’s Update – September 2022
As Summer closes, Rob reflects on the ESMO conference, a new Chair in Neuro-Oncology, launching a new podcast platform, and the latest Director's Lecture from Bob Tillman.
Impact Case Study
Changing clinical practice for patients with Lymphoma
We hear from Professor John Radford and Professor Tim Illidge who have been leading international research efforts in both Hodgkin and non-Hodgkin lymphoma.
Podcast
23/09/2022
One in Two: A Manchester Cancer Research Podcast
Research Spotlight
22/09/2022
Guidelines on breast cancer surgery need revision, find researchers
Current international breast cancer surgery guidelines need urgent revision, according to a meta-analysis of 68 studies comprising 112,140 patients by University of Manchester researchers.
Partner News
20/09/2022
Leading brain cancer expert appointed as inaugural brain tumour charity neuro-oncology chair in Manchester
Partner News
31/08/2022
The Christie is the first UK hospital to become a European Prostate Cancer Centre of Excellence
The Christie is recognised across three corse areas: clinical care, research and education
Research Spotlight
26/08/2022
Scientists unlock potential for a small cell lung cancer blood test
MCRC Blog
26/08/2022
ACCESS 4 LGBTQIA+ event
For this year’s Manchester Pride, we recognise the huge support within the MCRC for our vision of Equality, Diversity and Inclusion (EDI) in education.
Director's Update
04/08/2022
MCRC Director’s Update – July 2022
MCRC Blog
06/07/2022
Forging Collaborations on an International Scale – MCRC Visit Kenya
Members of the MCRC, University of Manchester and The Christie visited KUTRRH in June to build on existing collaborations to improve cancer survival.
Director's Update
29/06/2022
MCRC Director’s Update – June 2022
MCRC Blog
27/06/2022
Early detection in hereditary cancers
We speak to Dr Emma Woodward about a cost-effectiveness model of renal cell carcinoma (RCC) surveillance in hereditary leiomyomatosis and renal cell carcinoma (HLRCC)
Training and Development
16/06/2022
MB-PhD Summer Placements 2022
This year we are again offering University of Manchester MBChB and University of St Andrews Medicine Manchester pathway students summer research opportunities to introduce them to our MB-PhD supervisors and cancer research themes.
